Bank Of New York Mellon Corp Immuneering Corp Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.89 - $7.81 $188,396 - $378,246	-48,431 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$6.47 - $16.99 $158,877 - $417,206	24,556 Added 102.85%	48,431 $314,000
Q4 2021 Feb 11, 2022	BUY	$16.12 - $31.02 $52,809 - $101,621	3,276 Added 15.9%	23,875 $386,000
Q3 2021 Nov 12, 2021	BUY	$17.0 - $32.84 $350,183 - $676,471	20,599 New	20,599 $547,000

4.64M

Ticker IMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,392,300
Market Cap $57.8M
Description
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.